Literature DB >> 27120085

Comparison of Cherenkov excited fluorescence and phosphorescence molecular sensing from tissue with external beam irradiation.

Huiyun Lin1, Rongxiao Zhang, Jason R Gunn, Tatiana V Esipova, Sergei Vinogradov, David J Gladstone, Lesley A Jarvis, Brian W Pogue.   

Abstract

Ionizing radiation delivered by a medical linear accelerator (LINAC) generates Cherenkov emission within the treated tissue. A fraction of this light, in the 600-900 nm wavelength region, propagates through centimeters of tissue and can be used to excite optical probes in vivo, enabling molecular sensing of tissue analytes. The success of isolating the emission signal from this Cherenkov excitation background is dependent on key factors such as: (i) the Stokes shift of the probe spectra; (ii) the excited state lifetime; (iii) the probe concentration; (iv) the depth below the tissue surface; and (v) the radiation dose used. Previous studies have exclusively focused on imaging phosphorescent dyes, rather than fluorescent dyes. However there are only a few biologically important phosphorescent dyes and yet in comparison there are thousands of biologically relevant fluorescent dyes. So in this study the focus was a study of efficacy of Cherenkov-excited luminescence using fluorescent commercial near-infrared probes, IRDye 680RD, IRDye 700DX, and IRDye 800CW, and comparing them to the well characterized phosphorescent probe Oxyphor PtG4, an oxygen sensitive dye. Each probe was excited by Cherenkov light from a 6 MV external radiation beam, and measured in continuous wave or time-gated modes. The detection was performed by spectrally resolving the luminescence signals, and measuring them with spectrometer-based separation on an ICCD detector. The results demonstrate that IRDye 700DX and PtG4 allowed for the maximal signal to noise ratio. In the case of the phosphorescent probe, PtG4, with emission decays on the microsecond (μs) time scale, time-gated acquisition was possible, and it allowed for higher efficacy in terms of the probe concentration and detection depth. Phantoms containing the probe at 5 mm depth could be detected at concentrations down to the nanoMolar range, and at depths into the tissue simulating phantom near 3 cm. In vivo studies showed that 5 nmol of dye was readily detected with radiation doses less than 5 cGy. Since concentration, radiation dose and depth each contribute to the level of the detected signal, it may be possible to improve any of these parameters at expense of the others. This paradigm of nanoMolar sensitivity for optical reporters in vivo introduces the concept of molecular sensing of tumors during therapy or diagnostically with biologically relevant concentrations of fluorescent reporters.

Entities:  

Mesh:

Year:  2016        PMID: 27120085     DOI: 10.1088/0031-9155/61/10/3955

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  11 in total

1.  Cerenkov Radiation-Induced Photoimmunotherapy with 18F-FDG.

Authors:  Yuko Nakamura; Tadanobu Nagaya; Kazuhide Sato; Shuhei Okuyama; Fusa Ogata; Karen Wong; Stephen Adler; Peter L Choyke; Hisataka Kobayashi
Journal:  J Nucl Med       Date:  2017-04-13       Impact factor: 10.057

Review 2.  Optical and x-ray technology synergies enabling diagnostic and therapeutic applications in medicine.

Authors:  Brian W Pogue; Brian C Wilson
Journal:  J Biomed Opt       Date:  2018-10       Impact factor: 3.170

3.  Is Tumor Cell Specificity Distinct from Tumor Selectivity In Vivo?: A Quantitative NIR Molecular Imaging Analysis of Nanoliposome Targeting.

Authors:  Girgis Obaid; Kimberley Samkoe; Kenneth Tichauer; Shazia Bano; Yeonjae Park; Zachary Silber; Sassan Hodge; Susan Callaghan; Mina Guirguis; Srivalleesha Mallidi; Brian Pogue; Tayyaba Hasan
Journal:  Nano Res       Date:  2020-11-27       Impact factor: 8.897

4.  Signal intensity analysis and optimization for in vivo imaging of Cherenkov and excited luminescence.

Authors:  Ethan P M LaRochelle; Jennifer R Shell; Jason R Gunn; Scott C Davis; Brian W Pogue
Journal:  Phys Med Biol       Date:  2018-04-20       Impact factor: 3.609

5.  Cherenkov excited short-wavelength infrared fluorescence imaging in vivo with external beam radiation.

Authors:  Xu Cao; Shudong Jiang; Mengyu Jeremy Jia; Jason R Gunn; Tianshun Miao; Scott C Davis; Petr Bruza; Brian W Pogue
Journal:  J Biomed Opt       Date:  2018-11       Impact factor: 3.170

6.  Comparison of phosphorescent agents for noninvasive sensing of tumor oxygenation via Cherenkov-excited luminescence imaging.

Authors:  Jennifer Shell; Ethan P LaRochelle; Petr Bruza; Jason Gunn; Lesley Jarvis; David Gladstone; Brian Pogue
Journal:  J Biomed Opt       Date:  2019-03       Impact factor: 3.170

7.  Theoretical lateral and axial sensitivity limits and choices of molecular reporters for Cherenkov-excited luminescence in tissue during x-ray beam scanning.

Authors:  Ethan P M LaRochelle; Brian W Pogue
Journal:  J Biomed Opt       Date:  2020-11       Impact factor: 3.170

Review 8.  Mechanisms for Tuning Engineered Nanomaterials to Enhance Radiation Therapy of Cancer.

Authors:  Sandhya Clement; Jared M Campbell; Wei Deng; Anna Guller; Saadia Nisar; Guozhen Liu; Brian C Wilson; Ewa M Goldys
Journal:  Adv Sci (Weinh)       Date:  2020-10-28       Impact factor: 16.806

9.  Review of in vivo optical molecular imaging and sensing from x-ray excitation.

Authors:  Brian W Pogue; Rongxiao Zhang; Xu Cao; Jeremy Mengyu Jia; Arthur Petusseau; Petr Bruza; Sergei A Vinogradov
Journal:  J Biomed Opt       Date:  2021-01       Impact factor: 3.170

10.  A Novel Theranostic Combination of Near-infrared Fluorescence Imaging and Laser Irradiation Targeting c-KIT for Gastrointestinal Stromal Tumors.

Authors:  Shota Fujimoto; Naoki Muguruma; Koichi Okamoto; Takeshi Kurihara; Yasushi Sato; Yoshihiko Miyamoto; Shinji Kitamura; Hiroshi Miyamoto; Takahiro Taguchi; Koichi Tsuneyama; Tetsuji Takayama
Journal:  Theranostics       Date:  2018-03-21       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.